64Cu(II)Cl2 solution for injection
Sponsors
A.C.O.M. Advanced Center Oncology Macerata S.r.l.
Conditions
Cancer on the prostatic bedProstate cancer at risk of developing metastatic lesions
Phase 3
Use of 64CuCl2 PET/CT Imaging in the selection of patients with prostate cancer in biochemical relapse after prostatectomy, to be successfully treated with salvage radiotherapy on the prostatic bed.
Not yet recruitingCTIS2025-520868-17-00
Target: 138Updated: 2025-09-10
Higher diagnostic accuracy of 64Cu PET/CT compared to standard 18F-choline PET/CT in the detection rate of metastasis from prostate cancer.
Not yet recruitingCTIS2025-520861-29-00
Target: 285Updated: 2025-09-10